Editas Medicine, Inc.
DE ˙ DB ˙ US28106W1036
2,35 € ↑0,04 (1,73%)
2026-06-04
AKTIENPREIS
SecurityDE:8EM / Editas Medicine, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in 8EM / Editas Medicine, Inc.

2026-03-26 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Editas Medicine, Inc. (DE:8EM). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-11-12 , Vanguard Group Inc had reported owning 6,679,450 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-03-26 2026-03-26 13G/A 6,679,450 0 -100.00 0.00 -100.00
2024-11-12 2024-11-12 13G/A 6,679,450 6,679,450 0.00 8.09 0.00
2024-11-04 2024-11-04 13G/A 8,461,701 6,679,450 -21.06 8.09 -21.91
2024-02-13 2024-02-13 13G/A 6,873,123 8,461,701 23.11 10.36 3.60
2023-02-09 2023-02-09 13G/A 7,328,042 6,873,123 -6.21 10.00 -6.45
2022-03-09 2022-03-09 13G/A 6,673,897 7,328,042 9.80 10.69 9.53
2022-02-09 2022-02-09 13G/A 5,824,886 6,673,897 14.58 9.76 4.50
2021-02-10 2021-02-10 13G/A 4,567,616 5,824,886 27.53 9.34 4.94
2020-02-12 2020-02-12 13G/A 3,862,012 4,567,616 18.27 8.90 10.29
2019-02-11 2019-02-11 13G/A 2,768,403 3,862,012 39.50 8.07 28.71
2018-02-08 2018-02-08 13G 2,768,403 6.27

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F EDITAS MEDICINE COM 28106W103 8,208,068 1,242,450 17.84 16,827 -30.38 0.0002
2025-11-07 2025-09-30 13F EDITAS MEDICINE COM 28106W103 6,965,618 -193,874 -2.71 24,171 53.46 0.0004
2025-08-11 2025-06-30 13F EDITAS MEDICINE COM 28106W103 7,159,492 -306,762 -4.11 15,751 81.87 0.0003
2025-05-09 2025-03-31 13F EDITAS MEDICINE COM 28106W103 7,466,254 643,256 9.43 8,661 -0.06 0.0002
2025-02-11 2024-12-31 13F EDITAS MEDICINE COM 28106W103 6,822,998 143,392 2.15 8,665 -61.96 0.0002
2024-11-13 2024-09-30 13F EDITAS MEDICINE COM 28106W103 6,679,606 -1,352,998 -16.84 22,777 -39.28 0.0004
2024-08-13 2024-06-30 13F EDITAS MEDICINE COM 28106W103 8,032,604 -522,993 -6.11 37,512 -40.91 0.0007
2024-05-10 2024-03-31 13F EDITAS MEDICINE COM 28106W103 8,555,597 93,740 1.11 63,483 -25.94 0.0013
2024-03-11 2023-12-31 13F/A-1 EDITAS MEDICINE COM 28106W103 8,461,857 -74,351 -0.87 85,719 28.74 0.0019
2024-02-14 2023-12-31 13F EDITAS MEDICINE COM 28106W103 8,461,857 -74,351 85,719 0.0016
2023-12-18 2023-09-30 13F/A-1 EDITAS MEDICINE COM 28106W103 8,536,208 370,734 4.54 66,582 -0.92 0.0016
2023-11-14 2023-09-30 13F EDITAS MEDICINE COM 28106W103 8,536,208 370,734 66,582 0.0016
2023-08-14 2023-06-30 13F EDITAS MEDICINE COM 28106W103 8,165,474 962,760 13.37 67,202 28.69 0.0016
2023-07-14 2023-03-31 13F/A-1 EDITAS MEDICINE COM 28106W103 7,202,714 329,591 4.80 52,220 -14.34 0.0013
2023-05-15 2023-03-31 13F EDITAS MEDICINE COM 28106W103 7,199,714 326,591 52,198 0.0003
2023-02-10 2022-12-31 13F EDITAS MEDICINE COM 28106W103 6,873,123 147,783 2.20 60,965 -25.94 0.0017
2022-11-14 2022-09-30 13F EDITAS MEDICINE COM 28106W103 6,725,340 89,730 1.35 82,318 4.87 0.0024
2022-08-12 2022-06-30 13F EDITAS MEDICINE COM 28106W103 6,635,610 -240,929 -3.50 78,499 -39.98 0.0022
2022-05-13 2022-03-31 13F EDITAS MEDICINE COM 28106W103 6,876,539 202,642 3.04 130,792 -26.19 0.0031
2022-02-14 2021-12-31 13F EDITAS MEDICINE COM 28106W103 6,673,897 230,747 3.58 177,192 -33.06 0.0040
2021-11-12 2021-09-30 13F EDITAS MEDICINE COM 28106W103 6,443,150 -40,782 -0.63 264,685 -27.93 0.0066
2021-08-13 2021-06-30 13F EDITAS MEDICINE COM 28106W103 6,483,932 136,178 2.15 367,250 37.75 0.0091
2021-05-14 2021-03-31 13F EDITAS MEDICINE COM 28106W103 6,347,754 522,868 8.98 266,606 -34.72 0.0072
2021-02-12 2020-12-31 13F EDITAS MEDICINE COM 28106W103 5,824,886 116,850 2.05 408,383 154.97 0.0118
2020-11-16 2020-09-30 13F EDITAS MEDICINE COM 28106W103 5,708,036 -52,437 -0.91 160,168 -6.00 0.0053
2020-08-14 2020-06-30 13F EDITAS MEDICINE COM 28106W103 5,760,473 1,048,440 22.25 170,395 82.36 0.0060
2020-05-15 2020-03-31 13F EDITAS MEDICINE COM 28106W103 4,712,033 144,417 3.16 93,439 -30.91 0.0040
2020-02-14 2019-12-31 13F EDITAS MEDICINE COM 28106W103 4,567,616 248,851 5.76 135,247 37.71 0.0046
2019-11-14 2019-09-30 13F EDITAS MEDICINE COM 28106W103 4,318,765 27,904 0.65 98,209 -7.49 0.0036
2019-08-14 2019-06-30 13F EDITAS MEDICINE COM 28106W103 4,290,861 355,256 9.03 106,156 10.32 0.0040
2019-05-15 2019-03-31 13F EDITAS MEDICINE COM 28106W103 3,935,605 73,593 1.91 96,225 9.52 0.0038
2019-02-14 2018-12-31 13F EDITAS MEDICINE COM 28106W103 3,862,012 132,433 3.55 87,860 -25.97 0.0039
2018-12-13 2018-09-30 13F/A-2 EDITAS MEDICINE COM 28106W103 3,729,579 141,609 3.95 118,675 -7.69 0.0046
2018-11-23 2018-09-30 13F/A-1 EDITAS MEDICINE COM 28106W103 3,729,579 0 118,675 0.0046
2018-11-14 2018-09-30 13F EDITAS MEDICINE COM 28106W103 3,729,579 141,609 118,675
2018-08-14 2018-06-30 13F EDITAS MEDICINE COM 28106W103 3,587,970 571,862 18.96 128,557 28.58 0.0054
2018-05-15 2018-03-31 13F EDITAS MEDICINE COM 28106W103 3,016,108 247,705 8.95 99,984 17.53 0.0044
2018-02-14 2017-12-31 13F EDITAS MEDICINE COM 28106W103 2,768,403 471,648 20.54 85,074 54.27 0.0037
2017-11-14 2017-09-30 13F EDITAS MEDICINE COM 28106W103 2,296,755 119,609 5.49 55,146 50.95 0.0026
2017-08-24 2017-06-30 13F/A-1 EDITAS MEDICINE COM 28106W103 2,177,146 241,973 12.50 36,533 -15.42 0.0018
2017-08-11 2017-06-30 13F EDITAS MEDICINE COM 28106W103 2,177,146 241,973 36,533
2017-05-12 2017-03-31 13F EDITAS MEDICINE COM 28106W103 1,935,173 618,789 47.01 43,193 102.17 0.0022
2017-02-14 2016-12-31 13F EDITAS MEDICINE COM 28106W103 1,316,384 66,825 5.35 21,365 26.84 0.0012
2016-11-14 2016-09-30 13F EDITAS MEDICINE COM 28106W103 1,249,559 716,590 134.45 16,844 29.53 0.0010
2016-08-10 2016-06-30 13F EDITAS MEDICINE COM 28106W103 532,969 -217,323 -28.97 13,004 -49.82 0.0008
2016-05-13 2016-03-31 13F EDITAS MEDICINE COM 28106W103 750,292 750,292 25,915 0.0017
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.